Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124954) titled 'Randomized Controlled Trial of Early Low-Dose Aspirin Use After Intravenous Thrombolysis in Acute Cerebral Infarction Patients' on May 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Chao-Yang Hospital, Capital Medical University
Condition:
Acute cerebral infarction
Intervention:
Early use of aspirin group:Early use of aspirin after rt-PA thrombolysis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-19
Target Sample Size: Early use of aspirin group:105;Control group:105;
Countries of Recruitment:
China
To know more, visit https://...